Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease
Authors:
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 135, 144-156
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673134, 81401570, 81171191)
- Shenzhen Special Fund Project on Strategic Emerging Industry Development (JCYJ2016042814343376, JCYJ20170818111012390, JCYJ20160422143433757, JCYJ20170810163329510)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201611090)
This publication has 52 references indexed in Scilit:
- Eye opening and PSD95 are required for long-term potentiation in developing superior colliculusProceedings of the National Academy of Sciences, 2012
- Morin attenuates tau hyperphosphorylation by inhibiting GSK3βNeurobiology of Disease, 2011
- RETRACTED ARTICLE: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in gliomaJournal of Neuro-Oncology, 2011
- Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseasesBrain Research Reviews, 2011
- Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrinProceedings of the National Academy of Sciences, 2010
- Mitofusins and OPA1 Mediate Sequential Steps in Mitochondrial Membrane FusionMolecular Biology of the Cell, 2009
- Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticityNeuropharmacology, 2008
- Human Protein Reference Database--2009 updateNucleic Acids Research, 2008
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and LearningCell, 2008
- Dynamic regulation of PGC‐1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress responseAging Cell, 2007